The Role of PD-L1 Testing in Advanced Genitourinary Malignancies

被引：7
|
作者：
Hahn, Andrew W. [1 ]
Sirohi, Deepika [1 ]
Agarwal, Neeraj [1 ]
机构：
[1] Univ Utah, Dept Internal Med, Div Oncol, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA
来源：
EUROPEAN UROLOGY FOCUS | 2020年 / 6卷 / 01期
关键词：
METASTATIC UROTHELIAL CARCINOMA; MULTICENTER; NIVOLUMAB; THERAPY;
D O I：
10.1016/j.euf.2019.03.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 13
页数：3
相关论文
共 50 条
  • [41] PD-L1 testing by immunohistochemistry in immuno-oncology
    Vranic, Semir
    Gatalica, Zoran
    [J]. BIOMOLECULES AND BIOMEDICINE, 2023, 23 (01): : 15 - 25
  • [42] PD-L1 testing in urothelial carcinoma: are we there yet?
    van Leenders, Geert J. L. H.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S466 - S468
  • [43] Reply to: Problems With the Recommendations for PD-L1 Biomarker Testing
    Torlakovic, Emina E.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (07) : E65 - E67
  • [44] Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
    Heigener, David F.
    Reck, Martin
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S1468 - S1473
  • [45] An Update of a Pooled Analysis of Nivolumab for the Treatment of Advanced NSCLC and the Role of PD-L1 as a BIOMARKER
    Aguiar, Pedro, Jr.
    De Mello, Ramon
    Santoro, Ilka
    Tadokoro, Hakaru
    Barreto, Carmelia
    Oliveira, Pedro
    Lopes, Gilberto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S245 - S245
  • [46] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
  • [47] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    [J]. CANCER RESEARCH, 2016, 76
  • [48] Role of PD-L1 and PD-L2 in allergic diseases and asthma
    Singh, A. K.
    Stock, P.
    Akbari, O.
    [J]. ALLERGY, 2011, 66 (02) : 155 - 162
  • [49] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [50] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
12345